USO0RE40833E

(19) United States (12) Reissued Patent Wintermantel et al. (54)

(10) Patent Number:

US RE40,833 E

(45) Date of Reissued Patent:

MEDICINAL PRODUCT WITH A TEXTILE COMPONENT

(52)

Jul. 7, 2009

US. Cl. ...................... .. 428/131; 428/156; 428/141;

602/42; 602/43; 602/44; 602/45; 602/47; 623/2376; 623/2374

(75) Inventors: Erich Wintermantel, Niederrohrdorf

(CH); Jorg Mayer, NiederlenZ (CH); Erdal Karamuk, Zollikerberg (CH);

(58)

428/156; 141; 602/42; 43; 44; 45; 47; 623/23.76; 623/23.74

Roland Seidl, WattWil (CH); Barbel Wagner, St. Gallen (CH); Bernhard Bischoff, Gossau (CH); Mario Billia,

MunchWilen (CH)

See application ?le for complete search history. (56)

(73) Assignee: Tissupor AG, St. Gallen (CH) (21) Appl. No.1 PCT Filed:

Jan. 28, 2000

(86)

PCT No.1

PCT/CH00/00041

8371 (0X1)’ (2), (4) Date: (87)

Oct. 29, 2001

PCT Pub. No.1 WO00/45761

PCT Pub. Date: Aug. 10, 2000 Related US. Patent Documents

Reissue of:

(64) Patent No.1 Issued:

(30)

6,737,149 May 18, 2004

Appl. No.1

09/890,635

Filed:

Oct. 29, 2001

Foreign Application Priority Data

References Cited U.S. PATENT DOCUMENTS

11/436,184

(22)

Field of Classi?cation Search ................ .. 428/131,

4,047,252 A 5,569,273 A 5,990,378 A

9/1977 Liebig et a1. 10/1996 Titone et a1. 11/1999 Ellis

FOREIGN PATENT DOCUMENTS GB

2 252 528 A

8/1992

Primary Examineriwilliam P Watkins, III (74) Attorney, Agent, or FirmiThe Webb LaW Firm

(57)

ABSTRACT

The present invention relates to a medicinal product With a textile component such as a Wound compress having a sur

face containing a multiplicity of openings arranged in at least tWo hole patterns. The diameter of one opening of one hole pattern deviates from the diameter of an opening of another hole pattern by about at least a factor of 5. Better

Wound healing is achieved by adapting the structural and Feb. 4, 1999

(51)

(EP) .......................................... .. 99810089

Int. Cl. B32B 3/24 A61F 2/02

(2006.01) (2006.01)

mechanical characteristics of the medicinal product to the characteristics of the target tissue.

13 Claims, 2 Drawing Sheets

US. Patent

Jul. 7, 2009

Sheet 1 of2

US RE40,833 E

10

1| 1

12

13

Fig. 3

US. Patent

Jul. 7, 2009

Sheet 2 of2

US RE40,833 E

12

17

13

‘f

""

I’

7 '* I’ ‘pa

US RE40,833 E 1

2

MEDICINAL PRODUCT WITH A TEXTILE COMPONENT

set out in the introduction and which speci?cally in?uences

and promotes angiogenesis and the healing process associ ated with the latter.

Matter enclosed in heavy brackets [ ] appears in the original patent but forms no part of this reissue speci?ca tion; matter printed in italics indicates the additions made by reissue.

It is also an aim of the invention to ensure that such a

medical product also remains soft in its textile component even after prolonged contact with the wound. A further aim of the invention is to ensure that the rigid ness of such a medical product can be preset individually at

BACKGROUND OF THE INVENTION

the time of production.

1. Field of the Invention The invention relates to a medical product with a textile

Finally, it is also a further object of the invention to

improve angiogenesis and consequently the tissue regenera tion in leg ulcers, for example. According to the invention, this object is achieved by the

component, for example a wound compress, having the fea tures of a multiplicity of openings, with at least two patterns of holes with groups of openings, the diameter of one open ing of one hole pattern deviating from the diameter of an opening of another hole pattern in each case by about at least

fact that the surface has a multiplicity of openings, there being at least two patterns of holes with groups of openings, the diameter of one opening of one hole pattern deviating from the diameter of an opening of another hole pattern in

a factor of 5 from one another.

2. Description of the Related Art In the medical sector, a number of textile products are known which are intended to externally promote wound

healing, for example. Known medical products such as wound compresses consist for example of woven fabric, which has the disadvantage that it has a hard surface which adapts poorly to the wound. For this reason, many wound

each case by about at least a factor of 5 from one another. 20

25

wounds is considerably reduced, which is important to the economy. These advantages are achieved by adapting the structural and mechanical properties of the medical product to the properties of the tissue in question. In the case of leg ulcers, the main focus of wound healing

30

lies in the regeneration of a physiologically functional vas cular system. Wound healing is to be seen in the context of

compresses are made up of knitted fabrics which are soft per

se. They also have some degree of moisture absorbency. The softness of knitted fabrics arises from the movement of the threads within the interfacing. These abovementioned

wound products have the disadvantage that they harden because of exudates emerging from the wound and thus lose

their functional ability.

scar tissue formation. An intensive scar tissue formation

Known compresses have semipermeable membranes of

polyurethane which permit the passage and exchange of gases and ?uids and have in particular nonadhesive materials on the surface facing the wound in order to prevent them from ?rmly sticking to the wound. This very type of com

35

structed in compact parallel bundles, whereas the meshwork in undamaged skin has mechanically better properties. 40

SUMMARY OF THE INVENTION 45

in other places. A corresponding technique is described in Us. Pat. No. 5,569,273 which describes a hexagonal net

structure of polypropylene mono?lament yarns. Large open ings are constructed between adjacent vertical mesh rows, into which body tissue can grow into the implant because of the pore structure. However, this product does not promote

angiogenesis.

Rapid vasculariZation can lead to uncontrolled formation

of the skin capillary system. The capillaries themselves in?uence the orientation of the collagen ?bers.

intended in particular to permit less sticking to the wound.

Further possible uses of medical products with a textile component are, for example, the treatment of abdominal wall defects in the groin area or for strengthening soft tissue

inconveniences the patient because of the poor cosmetic aspect and in particular because of limited mobility. Both of these lead to personal anxiety and in many cases to disabil ity. When the wound has healed, there is unfortunately con nective scar tissue left in which the collagen matrix is recon

press is not able to speci?cally promote the angiogenesis which is achieved with the surface structure according to the invention. U.S. Pat. No. 5,465,735 describes such a multi layer wound dressing with a dense nonwoven which is

The advantage for the patient of using medical products according to the invention lies in the more rapid wound healing, in the reduction of the pain associated with wound treatment, in the shorter time spent in an inpatient department, and in the fact that the cost of treating such

Mechanical signals in the form of the exertion of a con trolled pull on the cells in the wound bed can represent an

important activator of the wound response. Mechanical in?uences on the wound also play a part in collagen genesis because modi?ed stresses during wound closure in?uence scarring. It is assumed that in order to form a normal col

50

lagen architecture a de?ned physiological mechanical stimu lation is required with respect to loading and orientation. In the case of scar tissue, by contrast, the anisotropy of the collagen network and the dimensions of the collagen ?bers are increased.

55

In contrast to the feature of nonadhesion to the wound

EP 870 820 discloses a nonadhesive wound dressing which, across its active area, has depressions containing a

bed, on which feature emphasis is placed in the prior art, growth of tissue into the medical article is here desired and

pharmaceutical carrier substance. The depressions are intended only for receiving and delivering an active sub stance. The nonadhesion of the wound dressing is empha sized.

advantageous. 60

and positively in?uences angiogenesis by acting as a frame work. The support for the layer according to the invention is dependent on the application. The use of the medical prod

Finally, EP 931 012 describes a compress which is used

for treating wounds in a moist environment and which, by means of an appropriate choice of dressing material, is like wise intended not to adhere to the wound.

Taking this prior art as a basis, it is an object of the inven tion to make available a medical product which is of the type

The invention makes available a wound treatment system developed on a textile basis which controls tissue formation

ucts according to the invention is possible in many areas. 65

One area of use concerns the treatment of large wounds,

burns or in surgical applications, for example for hernia meshes. These procedures require treatment systems which

US RE40,833 E 3

4

make it possible to minimize scar formation. At the same

trude from the side facing aWay from the Wound surface. The

time, it is also possible for the medical products to include mannose-6-phosphate or other collagen-regulating means, or factors Which promote tissue regeneration, for example growth factors of the TGF-b family. The medical product can be used in many applications

stimulation points 13 can all be the same siZe or can differ in

siZe individually or in groups. The Word “size” in this case

refers both to the height above and beloW the surface of the embroidery and also to the surface area in the plan vieW of the ?gures. Gradients in siZe can be provided, for example With the stimulation points 13 With the largest surface area and the smallest thickness in the middle of an embroidery, and the stimulation points 13 With the smallest surface area and the greatest thickness at the edges of the embroidery.

Where the embroidery-speci?c properties such as the con trolled mechanical properties of an embroidery, the local

variation in the mechanical design and the speci?c porosity can be of great advantage. In addition to the stated com

Any other combination of thicknesses and surface areas can be used. An embroidered structure 12 and thus an angiopolar layer is thus provided near the Wound. An angiopolar layer is a

presses and hernia meshes, these include abdominal Wall

replacements, arti?cial blood vessels and arti?cial liga ments. In the case of the latter, the embroidery technique can be used to pass from a ?rst speci?c structure, Where the ligament is to groW on and Where load transmission takes place, to a second and different structure in the ligament area. A further application is the formation of augmentation embroideries for reconstruction of the jaW bone in the dental

layer Which permits the speci?c oriented groWth of blood vessels into a structure and thus in?uences the density and

orientation of the blood vessels in the regenerated tissue. This embroidered structure 12 introduces morphological features into Wound treatment Which induce and stimulate a

sector.

Depending on the desired mechanical and structural prop erties of the textile, different yarn types are used. These can include ?brous, multi?lament or mono?lament yarns, Which

20

can also be untreated, antimicrobially pretreated, gel-coated

mechanical support, forms a reservoir for exudates and per

mits optimum control of moisture and gas transport.

and can be present in different titers.

By using embroidery technology, the knot siZe and the

25

nature of the linking can likeWise be preset.

needed for structural functions, for example pore pattern, for

The invention is described in more detail beloW on the

angiogenesis. The embroidery technique permits any desired 30

FIG. 1 is a diagrammatic cross section through a medical article according to one illustrative embodiment of the

invention, FIG. 2 is a diagrammatic plan vieW of a portion of the embroidered surface of a medical article according to the

35

FIG. 3 is an enlarged sectional vieW of the area of a pore 40

tion in a diagrammatic cross section. This medical article is

made up of three layers, for example. A base layer remote from the Wound consists of compact Woven fabric 10 Which has an antibacterial action. This also controls the oxygen and

45

Water content at the same time.

50

55

60

are therefore a support for the tissue-regenerating element. The embroidered surface, of Which FIG. 3 shoWs a section of the area of a pore 14 according to FIG. 2, has mesoscopic openings 24 in addition to the apertures or pores 14. The macroscopic apertures or pores 14 are produced by a plurality of links and have a siZe of the order of l to 2

millimeters edge length. They serve for ingroWth of tissue

produced embroidered layer 12 Which is preferably con nected at its side edges to the compress 1, for example by ultrasonic Welding. Reference number 13 denotes stimula tion points Which are formed in the layer 12, particularly in form ?at to semi-round protuberances, stimulation points 13, facing toWard the Wound surface and they can also pro

lying behind the embroidered surface 12 acts as a spacer and

siZe forming a cavity suitable for a blood coagulum. They

that is to say it has a cushion function and permits stress

the embroidery technique. In the form represented, they

illustrative embodiment shoWn. The embroidery technology also permits an irregular arrangement of the openings 14

bitus ulcers. The predetermined hole cross sections 17 have a

force takeup permits the distribution of local pressure loads,

compress 1 has an embroidered layer 12. The fabric 11 is designed as a spacer in relation to the antibacterial layer 10 and as a material Which takes up exudate. On this fabric 11, Which is advantageously formed as a knit, lies the separately

advantageous that the openings at the center of the compress 1 have the greatest aperture area and form corresponding cavities. In the illustrative embodiment according to FIG. 2, a gradient is provided With Which the diameters 17 of the openings provided decrease from the center to the edges. The openings 14 are arranged in a regular pattern in the

distributes the Weight upon loading in order to prevent decu

the mechanical binding of the compress material. The shear

distribution, Which leads to uniform loading of the Wound surface and thus avoids negative local stresses. Lastly, the

FIG. 2 shoWs a diagrammatic plan vieW of a portion of the embroidered surface 12 of a medical article 1 according to the invention. The structures designated With reference num ber 14 are openings Which are provided in the embroidered pattern and Which are substantially diamond-shaped here. In

according to further objectives, in particular With a variation in siZe. The fabric 11 mentioned With reference to FIG. 1 and

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

A spacer layer 11 With high shear force takeup consisting of gel-modi?ed yarns permits absorption and desorption and

use of materials in base fabrics.

other con?gurations, these shapes can also be rectangular, round, elliptic or have another shape. To positively stimulate angiogenesis, it is particularly

invention, and according to FIG. 2. FIG. 1 shoWs a medical article 1 according to the inven

With the embroidery technique, highly architectured three-dimensional textile structures are obtained Which are

basis of illustrative embodiments. BRIEF DESCRIPTION OF THE DRAWINGS

speci?c angiogenesis Within the frameWork and thus form the physiological basis for tissue reneWal. The textile architecture 11 and 12 creates optimum

plugs and as a reservoir for the blood coagulum from the

freshly bleeding Wound. The mesoscopic openings 24 permit ingroWth of indi 65

vidual blood vessel stems and have a siZe of approximately

100 to 500 micrometers. They are produced by interfacing of tWo yarn elements.

US RE40,833 E 5

6

Also shown here in diagrammatic representation are microscopic openings 34 With a diameter in the range of 5 to 50 micrometers Which permit the ingroWth of cells and cell aggregates With capillaries if necessary. These openings 34

controlled. Stiffening can cause local loading conditions

are betWeen different ?laments.

Which can lead to local tissue necrosis. In addition to the use of the embroidered element on a textile base such as a compress, other possible uses can also be envisaged. This can include the use of the embroidered

On a still smaller scale, small cavities in the range of 0.5 to 5 micrometers are present betWeen individual ?laments,

Wound-treating elements. The embroidery technique makes

surface material on a metallic or ceramic base or other

it possible to produce suitable surface elements for each

and only extracellular matrix, for example collagen material,

individual case.

can be deposited in these.

Having described presently preferred embodiments of the

The openings 14, 24 and 34 form groups of hole patterns. The openings 14, the openings 24 and the openings 34 are greater or smaller in relation to another group of openings by

20

invention, it is to be understood that it may be otherWise embodied Within the scope of the appended claims. We claim: 1. A medical product With a textile component Which forms a surface, said surface made from an embroidery, Wherein the surface has a multiplicity of openings, there being at least tWo patterns of holes With groups of openings, each said hole pattern having a surface, the diameter of one opening of one hole pattern deviating from the diameter of an opening of another hole pattern in each case by about at least a factor of 5 from one another, and Wherein a multiplic

25

ity of compact, rigid embroidered stimulation points is pro vided and centrally positioned betWeen the openings of the surface of each hole pattern, each said compact, rigid embroidered stimulation point having a surface, said stimu lation point surface protruding from the textile component

a factor of approximately at least 5. Within each group the openings can to a certain extent be the same siZe or can be of

different siZes. The distribution can be regular or also ran dom in the sense that a device for embroidering a textile

material controls the random distribution of the openings on the Whole surface of the textile material With the aid of a

random number generator. Reference number 13 denotes an embroidery point Which, in the illustrative embodiment shoWn, lies betWeen tWo

edges of the diamond-shaped openings 14. This embroidery point 13 is three-dimensional relative to the draWing plane and thus the plane of the embroidered layer 12 and has in particular a section protruding by 3 to 5 mm. In the illustra

by at most several millimeters as a ?at to semi-spherical

tive embodiment shoWn, this is almost semispherical, but

protruberance, and further Wherein the stimulation points

can also have other three-dimensional structures.

serve as an angiopolar layer that inhibits tissue ingroWth thereon.

For example, this embroidery point can also be three dimensional on the side pointing toWard the knitted spacer, in particular in order to form an abutment.

30

consisting of mono?laments, multi?laments, mixtures of

In contrast to known knits, the regular arrangement of the embroidery shoWn in the ?gures is not system-related and instead can be changed as desired in accordance With the use

on the basis of the embroidery technique. Thus, sequences of large and small apertures 14 are possible. As is shoWn in

35

FIG. 2, these can have a gradient. The sequence of embroi

dery points 13 and openings 14 is purely functional and not dictated by the manufacturing technology of the textile fab r1c.

40

It is also possible that the apertures or pores 14 are

spanned by a continuous thread 18 according to FIG. 3, Which for example runs from knot to knot in the embroidery of knots 13.

The interplay of the different hole siZes of the openings 14, 24, 34 favorably in?uences the ingroWth of blood vessels, so-called angiogenesis. Main groWths have a siZe of

50

dered compress material. Mono?laments, multi?laments or mixtures of these can

be used in the embroidery process. The strength of the embroidery can be determined through the choice of yarn and the speci?ed pattern. An advantage over a knit is that the thread cannot move in the interfacings, that is to say the

55

replacement, an arti?cial ligament and an augmentation tex tile for applications in the dental sector.

9. The medical product according to claim 1, Wherein the textile component comprises an embroidery material selected from the group consisting of natural, synthetic,

the incorporation of exudate or extracellular matrix into the

interfacing. Thus, an adhesive exudate leads to an increase in the rigidness of the textile in some circumstances far more than an order of siZe. This is a considerable disadvantage for

6. The medical product according to claim 4, Wherein each compact, rigid embroidered stimulation point has a height of betWeen about 3 to 5 millimeters. 7. The medical product according to claim 4, having tWo sides, Wherein the compact, rigid embroidered stimulation points protrude from the embroidered plane of the textile product on both sides of the textile product. 8. The medical product according to claim 1, Wherein the product comprises a product selected from the group con sisting of a compress, a hernia mesh, an abdominal Wall

mechanical properties of the embroidery are de?ned by the arrangements of the interfacings and are hardly affected by

thread, Which leads to the interfacings sticking together. In knits, by contrast, the mechanical properties are mainly de?ned by the movability of the thread through the open

mono?laments and multi?laments, and staple ?ber yarns. 3. The medical product according to claim 1, Wherein the hole pattern With the larger diameter of its openings and the hole pattern With the second largest diameter of its openings are arranged regularly. 4. The medical product according to claim 1, Wherein the hole pattern With the largest diameters has the largest open ing surface area in the middle of the product and decreases in a gradient toWard the edges of the product. 5. The medical product according to claim 4, Wherein the surface of the compact, rigid embroidered stimulation points correspond to the surface of the hole pattern With the largest diameters.

45

0.5 to 1 mm here. By means of the embroidery points it is possible to create a mechanical stimulation in the Wound

bed, Which affords an advantageous design of the embroi

2. The medical product according to claim 1, Wherein the embroidery comprises a structure selected from the group

inorganic and mineral raW materials. 60

10. The medical product according to claim 1, Wherein said textile component forms a ?rst layer, said medical prod uct further comprising a second layer Which is a knitted spacer layer and a third layer Which is a Woven base layer.

the medical product since the mechanical properties Which

11. The medical product according to claim 10, Wherein the second layer is capable of taking up exudates and absorb ing shear forces and the third layer has an antibacterial

are crucial for its medical functionality can no longer be

action.

65

US RE40,833 E 7

8

12. A method for providing medical product to promote

point surface protruding from the textile component by

Wound healing, comprising [he steps Of' 11) Provldmg ‘1 medlcal ProducZ Wllh ‘1 Zexllle component which forms a surface, said surface made from an embroidery, wherein the surface has a multiplicity of 5 openings, there being at least two patterns ofholes with groups of openings, each said hole pattern having a

at most several millimeters as a?at to semi-spherical protruberance, and further wherein the stimulation

Surface, l'he'dl'ameler 0/110”? Opening ofone hol? Pal[em dewazmg ?’Om {he dlamezer Of a” Openmg 0f another hole pattern in each case by about at least a

factor of5from one another, and wherein a multiplicity

of compact] rigid embroidered Stimulation POI-ms is provided between the openings of the surface ofeach

points serve as an angiopolar layer that inhibits tissue

ingrowth thereon; and b) applying said medicalproduct to a wound surface.

]3. The methodfor providing a medical product to pro mote wound healing of claim 12, wherein the embroidery .

.

_

_

mono?laments, multi?laments, mixtures of mono?laments and mulll?lamemsl and slaple?beryams

hole pattern, each said compact, rigid embroidered stimulation point having a surface, said stimulation

.

10 comprises a structure selected from the group consisting of

*

*

*

*

*

Medicinal product with a textile component

Jan 28, 2000 - structed in compact parallel bundles, whereas the meshwork .... spanned by a continuous thread 18 according to FIG. 3,. Which for example ...

701KB Sizes 2 Downloads 257 Views

Recommend Documents

Medicinal product with a textile component
Jan 28, 2000 - Foreign Application Priority Data. Feb. 4, 1999. (EP) . ... medical products such as wound compresses consist for example of woven fabric,.

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD ...
the field and allow you to write the name you wish to assign to you XEVPRM: 5) Type in the message number you wish to assign to your XEVPRM, then press "Enter" on your keyboard: 6) Expand the tree-view area by clicking on the "+" sign (see screenshot

Post-orphan medicinal product designation procedures: guidance
Jul 12, 2017 - page 6. - Information relating to Brexit under heading 9 added on ..... grounds that the paediatric indication brought a significant clinical benefit in comparison with existing ..... European Union, plus Icelandic and Norwegian.

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD ...
43 Winston Road. London. E14 5EU. UK. [email protected]. A sponsor organisation with the details: EraLab. Lockington Close. Margate. MA12 4JJ. UK.

eXtended EudraVigilance Medicinal Product Report Message ...
1) Log in to the requested EVWEB environment: EVWEB ...... 4) You can save the XML file of the XEVPRM ACK on your computer by going to "File" and selecting.

eXtended EudraVigilance Medicinal Product Report Message ...
eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step. Guide. EMA/525101/2014. Page 5/83. You are now logged in EVWEB – the organisation ID under which you are logged in is shown in the top right corner: 2) Go to "Create an

eXtended EudraVigilance Medicinal Product Dictionary - European ...
Apr 5, 2018 - 4) Select the organisation which you wish to update by clicking inside the relevant box; the information for the MAH will be loaded in the tree view. 5) Click on the Organisation information corresponding to "Nobel Company" already load

eXtended EudraVigilance Medicinal Product Report Message ...
Apr 5, 2018 - 1) Log in to the requested EVWEB environment: ...... on your keyboard or double-click with your mouse and the XML of the XEVPRM ACK.

eXtended EudraVigilance Medicinal Product Report Message ...
eXtended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step guide. EMA/543104/2014. Page 3/20. 1.1. Example specifications.

eXtended EudraVigilance Medicinal Product Dictionary - European ...
Apr 5, 2018 - eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) Step-by-Step Guide. EMA/197297/2018. Page 6/9. 4) Click inside the box of the result (i.e. the AMP that you wish to invalidate); the information for the. AMP will be loaded i

Non-animal approaches in support of medicinal product development ...
Oct 5, 2017 - Nature Review drug Discovery 3, 711-715. Hornberg et al 2014. Drug Discovery Today 19; 1131-1136. Most noted safety reasons for withdrawal of marketed drugs: •. Liver toxicity. •. Cardiovascular toxicity. •. CNS effects. Main reas

Non-animal approaches in support of medicinal product development ...
Oct 5, 2017 - Non-animal approaches in support of ... Cardiovascular toxicity >>> CNS, lung, adapative immune system ... for regulatory decision making.

Paediatric strategy forum for medicinal product development of
Apr 17, 2018 - Paediatric Strategy Forum for Medicinal Product Development of Checkpoint inhibitors for use in combination therapy in paediatric patients. EMA/242738/2018. Page 3/4. List of speakers and moderators. To be announced ...

Component Testing
Jul 8, 2002 - silicon atom. ... you really have to understand the nature of the atom. ..... often that you see a desktop computer burst into flames and burn down ...

Register of deadlines to put a medicinal product on the market in ...
Send a question via our website: website www.ema.europa.eu/contact. An agency of the ... names. EMEA-000331-PIP01-08-M01 Esomeprazole sodium/Esomeprazole magnesium ....

Textile chemistry.pdf
15) Describe the effect of acid and alkali on cotton fibre. 16) Discuss on importance of various properties involved in polymer to form. fibre. SECTION – C. III.

Textile Technology.pdf
Page 1 of 1. SHRI VAISHNAV VIDYAPEETH VISHWAVIDYALAYA. INDORE. Shri Vaishnav Entrance Test (SVET). Syllabus for PhD (Textile Technology). Section 1:- Logic and Data Interpretation. Section 2:- Quantitative Skills. Section 3:- Comprehension and Verbal

Component Testing
Jul 8, 2002 - use a meter to test suspect components and troubleshoot electronic circuits. ..... The valence electron is held loosely to the atom and moves.

Textile fabric with integrated electrically conductive fibers and clothing ...
Apr 29, 1998 - induce either a Wired or Wireless coupling betWeen the textile fabric and .... netWork (LAN), thus serving as an antenna for improved reception and ... Well as other features and advantages thereof Will be best understood by ...

pdf-1411\fashion-and-textile-design-with-photoshop-and-illustrator ...
... apps below to open or edit this item. pdf-1411\fashion-and-textile-design-with-photoshop-an ... ve-practice-required-reading-range-by-robert-hume.pdf.